LARRY MATHIS Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LARRY MATHIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LARRY MATHIS. LARRY MATHIS is Director in ALEXION PHARMACEUTICALS INC ($ALXN).
LARRY MATHIS in ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LARRY MATHIS: Director
Holdings: 29,456 shares
Current Value: $3,762,120
Latest Transaction: May 01 2013
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LARRY MATHIS in ALEXION PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 01 2013 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 99.03 | 3,115 | 308,478 | 29,456 | 32.6 K to 29.5 K (-9.56 %) |
Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Grant | A | 0.00 | 2,471 | 0 | 32,571 | 30.1 K to 32.6 K (+8.21 %) |
May 09 2012 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | A | 85.75 | 3,237 | 277,573 | 3,237 | |
Feb 21 2012 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | M | 5.73 | 24,000 | 137,520 | 0 | |
Feb 21 2012 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 81.23 | 5,450 | 442,704 | 11,115 | 16.6 K to 11.1 K (-32.90 %) |
Feb 21 2012 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 81.23 | 24,000 | 1,949,520 | 16,565 | 40.6 K to 16.6 K (-59.16 %) |
Feb 21 2012 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 5.73 | 24,000 | 137,520 | 40,565 | 16.6 K to 40.6 K (+144.88 %) |
Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 0.00 | 3,115 | 0 | 16,565 | 13.5 K to 16.6 K (+23.16 %) |
Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | M | 5.73 | 24,000 | 137,520 | 24,000 | |
Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 58.62 | 24,000 | 1,406,880 | 13,450 | 37.5 K to 13.5 K (-64.09 %) |
Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 5.73 | 24,000 | 137,520 | 37,450 | 13.5 K to 37.5 K (+178.44 %) |
May 13 2011 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | A | 98.86 | 2,786 | 275,424 | 2,786 | |
Feb 16 2011 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 89.08 | 3,965 | 353,202 | 6,725 | 10.7 K to 6.7 K (-37.09 %) |
Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 0.00 | 2,725 | 0 | 10,690 | 8 K to 10.7 K (+34.21 %) |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | S | 11.11 | 3,000 | 33,330 | 9,000 | |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | S | 9.87 | 2,000 | 19,740 | 13,000 | |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | S | 11.11 | 3,000 | 33,330 | 12,000 | |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 60.64 | 3,000 | 181,920 | 7,965 | 11 K to 8 K (-27.36 %) |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 11.11 | 3,000 | 33,330 | 10,965 | 8 K to 11 K (+37.66 %) |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 58.98 | 2,000 | 117,960 | 7,965 | 10 K to 8 K (-20.07 %) |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 9.87 | 2,000 | 19,740 | 9,965 | 8 K to 10 K (+25.11 %) |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 58.98 | 3,000 | 176,940 | 7,965 | 11 K to 8 K (-27.36 %) |
Sep 10 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 11.11 | 3,000 | 33,330 | 10,965 | 8 K to 11 K (+37.66 %) |
May 13 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | A | 53.28 | 3,966 | 211,308 | 3,966 | |
Feb 18 2010 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 46.37 | 5,089 | 235,977 | 7,965 | 13.1 K to 8 K (-38.98 %) |
Oct 27 2009 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | S | 9.87 | 13,000 | 128,310 | 2,000 | |
Oct 27 2009 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 48.42 | 13,000 | 629,460 | 9,089 | 22.1 K to 9.1 K (-58.85 %) |
Oct 27 2009 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | M | 9.87 | 13,000 | 128,310 | 22,089 | 9.1 K to 22.1 K (+143.03 %) |
Jul 30 2009 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 42.66 | 6,000 | 255,960 | 9,089 | 15.1 K to 9.1 K (-39.76 %) |
Feb 18 2009 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 39.53 | 4,000 | 158,120 | 11,089 | 15.1 K to 11.1 K (-26.51 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.05 | 100 | 7,105 | 5,000 | 5.1 K to 5 K (-1.96 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.04 | 200 | 14,208 | 5,100 | 5.3 K to 5.1 K (-3.77 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.04 | 100 | 7,104 | 5,300 | 5.4 K to 5.3 K (-1.85 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.04 | 100 | 7,104 | 5,400 | 5.5 K to 5.4 K (-1.82 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.02 | 100 | 7,102 | 5,500 | 5.6 K to 5.5 K (-1.79 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.00 | 100 | 7,100 | 5,600 | 5.7 K to 5.6 K (-1.75 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.02 | 100 | 7,102 | 5,700 | 5.8 K to 5.7 K (-1.72 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 70.99 | 100 | 7,099 | 5,800 | 5.9 K to 5.8 K (-1.69 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.02 | 100 | 7,102 | 5,900 | 6 K to 5.9 K (-1.67 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.02 | 100 | 7,102 | 6,000 | 6.1 K to 6 K (-1.64 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.01 | 100 | 7,101 | 6,100 | 6.2 K to 6.1 K (-1.61 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 71.01 | 137 | 9,728 | 6,200 | 6.3 K to 6.2 K (-2.16 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 70.98 | 600 | 42,588 | 6,337 | 6.9 K to 6.3 K (-8.65 %) |
May 15 2008 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Sell | S | 70.98 | 63 | 4,472 | 6,937 | 7 K to 6.9 K (-0.90 %) |
Page: 1